Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
about
A subnanomolar fluorescent probe for protein kinase CK2 interaction studiesFunctional analysis of protein kinase CK2 of the human malaria parasite Plasmodium falciparumEmergence of protein kinase CK2 as a key target in cancer therapyMining CK2 in cancerRegulation of CK2 by phosphorylation and O-GlcNAcylation revealed by semisynthesis.Protein kinase CK2--a key suppressor of apoptosis.Presynaptic CK2 promotes synapse organization and stability by targeting Ankyrin2.Casein kinase: the triple meaning of a misnomer.A complex signaling network involving protein kinase CK2 is required for hepatitis C virus core protein-mediated modulation of the iron-regulatory hepcidin gene expression.Pharmacological inhibition of protein kinase CK2 reverts the multidrug resistance phenotype of a CEM cell line characterized by high CK2 level.CK2 is a key regulator of SLC4A2-mediated Cl-/HCO3- exchange in human airway epithelia.Generation and quantitative proteomics analysis of CK2α/α'(-/-) cells.Characterizing the convergence of protein kinase CK2 and caspase-3 reveals isoform-specific phosphorylation of caspase-3 by CK2α': implications for pathological roles of CK2 in promoting cancer cell survival.Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.Re-evaluation of protein kinase CK2 pleiotropy: new insights provided by a phosphoproteomics analysis of CK2 knockout cells.Under-expression of CK2β subunit in ccRCC represents a complementary biomarker of p-STAT3 Ser727 that correlates with patient survival.
P2860
Q27682639-CDA07684-80D7-4EC8-B7C1-31E5E876F9E3Q27973597-FE1E8E4A-215D-4780-A791-633F8A63C706Q34046848-BD5B117F-2F84-4EA1-8FDF-33A4E0A03222Q34776090-5BD0E713-7495-4AC1-9258-FCE4C87C53F7Q35783386-E930F6EF-2F6E-4642-B2FA-C66E86D5E82AQ36994133-67B2A3D1-33D4-4263-9008-9140D5E915DEQ37441300-09512251-10B1-4407-A8A7-C505E353DF4DQ38211598-B74F127D-3F8E-45F5-B562-BB9487B7E5F0Q39005729-3FC2BD4A-4FB2-4216-BEBD-A6D11A46ED58Q40135888-3DAB5C8E-7019-469F-817A-3D82B77ABF22Q41368424-B224594B-CA40-4374-9AAD-435A817272F0Q41835528-3E49CB1A-875A-4357-8086-1ED9CDF2094CQ43078357-3FDDE5D4-0AA1-47E2-87FA-76C95D174C35Q47162634-15E5B9A0-5529-4D13-A166-586C50AF56DAQ47422811-4937F896-D26A-4F24-A23D-15D64301CB91Q50042975-ED758C79-49F3-434B-88F2-60F818E6EF2C
P2860
Discrimination between the activity of protein kinase CK2 holoenzyme and its catalytic subunits.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Discrimination between the act ...... me and its catalytic subunits.
@en
Discrimination between the act ...... me and its catalytic subunits.
@nl
type
label
Discrimination between the act ...... me and its catalytic subunits.
@en
Discrimination between the act ...... me and its catalytic subunits.
@nl
prefLabel
Discrimination between the act ...... me and its catalytic subunits.
@en
Discrimination between the act ...... me and its catalytic subunits.
@nl
P2093
P2860
P50
P1433
P1476
Discrimination between the act ...... me and its catalytic subunits.
@en
P2093
Emilio Itarte
Flavio Meggio
Oriano Marin
P2860
P304
P356
10.1016/J.FEBSLET.2006.06.031
P407
P577
2006-06-21T00:00:00Z